3D Tumour Organoid Models | NMI TT Pharmaservices

home contact company.overview news sitemap print privacy

Custom Cell Services


NMI-TT Contact Person

Dr. Christoph Sachse

+49 173 751 0585

Patient-derived 3D Tumour Organoid Models

Recent advances in the establishment of primary patient-derived tumour cell cultures hold great promise not only to improve our understanding of tumour biology, but also to significantly enhance the identification of truly individualised cancer therapies.

This is why we have partnered with cpo cellular phenomics & oncology GmbH, a company that has meanwhile sourced and cultured more than 200 different patient-derived 3D tumour cell models.

Together with cpo, we provide our clients with integrated compound testing services using PD3D® cell models.

    Our joint offerings:
  • Compound testing services by cpo
  • Back-up of phenotypic data by cpo's NGS-based genomic profiles
  • Generation of comprehensive proteomic and phospho-proteomic signatures (e.g., pre- vs post-treatment) via DigiWest or RPPA
Please email us to learn more about our services.



Linked in profile

NMI TT is a subsidiary of NMI